PACLX
Price
$37.36
Change
+$0.25 (+0.67%)
Updated
Jul 31 closing price
Net Assets
70.4B
VLAIX
Price
$33.78
Change
-$0.12 (-0.35%)
Updated
Jul 31 closing price
Net Assets
283.7M
Interact to see
Advertisement

PACLX vs VLAIX

PACLX vs VLAIX Comparison Chart in %
View a ticker or compare two or three
VS
PACLX vs. VLAIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PACLX is a StrongBuy and VLAIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PACLX has more cash in the bank: 70.4B vs. VLAIX (284M). VLAIX pays higher dividends than PACLX: VLAIX (2.19) vs PACLX (1.48). PACLX was incepted earlier than VLAIX: PACLX (22 years) vs VLAIX (11 years). PACLX (1.01) is less costly to investors than VLAIX (0.83). PACLX is a more actively managed with annual turnover of: 124.70 vs. VLAIX (14.00). PACLX has a lower initial minimum investment than VLAIX: PACLX (2500) vs VLAIX (100000). PACLX annual gain was more profitable for investors over the last year : 2.63 vs. VLAIX (-18.08). PACLX return over 5 years is better than : 6.11 vs. VLAIX (-24.21).
PACLXVLAIXPACLX / VLAIX
Total Expense Ratio0.980.83118%
Annual Report Gross Expense Ratio1.010.83122%
Fund Existence22 years11 years-
Gain YTD6.499-4.143-157%
Front LoadN/AN/A-
Min. Initial Investment25001000003%
Min. Initial Investment IRAN/AN/A-
Net Assets70.4B284M24,789%
Annual Yield % from dividends1.482.1967%
Returns for 1 year2.63-18.08-15%
Returns for 3 years18.73-14.25-131%
Returns for 5 years6.11-24.21-25%
Returns for 10 years59.7425.71232%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICTTX17.540.25
+1.45%
ICON Health and Information Tech Inv
KLCCX8.100.10
+1.25%
Federated Hermes Kaufmann Large Cap C
JHTCX21.380.11
+0.52%
JPMorgan Hedged Equity 3 C
MPGVX17.760.07
+0.40%
Mondrian Global Equity Value
JVMSX31.130.02
+0.06%
JHancock Disciplined Value Mid Cap R2